Myomo Research Development vs Total Operating Expenses Analysis

MYO Stock

USD 6.38 0.17 2.74%

Myomo financial indicator trend analysis is infinitely more than just investigating Myomo Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Myomo Inc is a good investment. Please check the relationship between Myomo Research Development and its Total Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Research Development vs Total Operating Expenses

Research Development vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Myomo Inc Research Development account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Myomo's Research Development and Total Operating Expenses is 0.96. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Myomo Inc, assuming nothing else is changed. The correlation between historical values of Myomo's Research Development and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Myomo Inc are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Research Development i.e., Myomo's Research Development and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Myomo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Myomo Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

At this time, Myomo's Tax Provision is very stable compared to the past year. As of the 12th of December 2024, Enterprise Value is likely to grow to about 148.6 M, while Selling General Administrative is likely to drop about 10.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	10.3M	10.3M	13.2M	13.8M
Total Revenue	13.9M	15.6M	19.2M	20.2M

Gross Profit Total Revenue

Myomo fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt
Total Assets		-0.44	0.66	0.68	0.83	0.95	0.76	-0.93	-0.79	0.66	0.95	0.61	-0.57	0.57	0.97	0.71	0.41	-0.41	0.84	0.62	0.86	0.89	-0.14	0.13	1.0	-0.02
Short Long Term Debt Total	-0.44		-0.59	-0.15	-0.71	-0.45	-0.51	0.49	0.46	-0.08	-0.36	-0.2	0.75	-0.18	-0.38	-0.57	-0.31	0.81	-0.48	-0.51	-0.42	-0.5	0.69	-0.03	-0.44	0.63
Other Current Liab	0.66	-0.59		0.82	0.45	0.6	0.9	-0.45	-0.91	0.29	0.47	0.75	-0.37	0.31	0.51	0.93	0.78	-0.27	0.88	0.92	0.64	0.79	0.06	0.43	0.64	0.13
Total Current Liabilities	0.68	-0.15	0.82		0.31	0.6	0.8	-0.38	-0.87	0.46	0.46	0.9	-0.06	0.36	0.52	0.78	0.66	0.01	0.82	0.77	0.64	0.82	0.36	0.56	0.65	0.54
Total Stockholder Equity	0.83	-0.71	0.45	0.31		0.87	0.54	-0.92	-0.56	0.54	0.83	0.28	-0.78	0.41	0.84	0.51	0.17	-0.82	0.65	0.43	0.73	0.75	-0.66	-0.13	0.84	-0.41
Net Tangible Assets	0.95	-0.45	0.6	0.6	0.87		0.7	-0.93	-0.8	0.63	0.92	0.53	-0.61	0.4	0.93	0.66	0.37	-0.54	0.87	0.62	0.83	0.9	-0.29	0.07	0.95	0.0
Property Plant And Equipment Net	0.76	-0.51	0.9	0.8	0.54	0.7		-0.56	-0.93	0.49	0.57	0.87	-0.26	0.48	0.61	0.98	0.78	-0.29	0.92	0.92	0.68	0.84	0.02	0.32	0.73	0.18
Net Debt	-0.93	0.49	-0.45	-0.38	-0.92	-0.93	-0.56		0.59	-0.58	-0.98	-0.32	0.7	-0.51	-0.98	-0.51	-0.2	0.55	-0.69	-0.42	-0.81	-0.74	0.38	0.08	-0.95	0.25
Retained Earnings	-0.79	0.46	-0.91	-0.87	-0.56	-0.8	-0.93	0.59		-0.48	-0.6	-0.83	0.38	-0.28	-0.64	-0.93	-0.74	0.31	-0.99	-0.94	-0.71	-0.94	-0.02	-0.36	-0.77	-0.27
Accounts Payable	0.66	-0.08	0.29	0.46	0.54	0.63	0.49	-0.58	-0.48		0.58	0.42	-0.1	0.19	0.63	0.48	0.44	-0.26	0.54	0.46	0.27	0.56	-0.08	-0.17	0.65	0.03
Cash	0.95	-0.36	0.47	0.46	0.83	0.92	0.57	-0.98	-0.6	0.58		0.37	-0.61	0.58	0.99	0.51	0.2	-0.4	0.69	0.4	0.84	0.73	-0.21	-0.04	0.96	-0.12
Non Current Assets Total	0.61	-0.2	0.75	0.9	0.28	0.53	0.87	-0.32	-0.83	0.42	0.37		0.05	0.46	0.42	0.82	0.6	0.0	0.77	0.77	0.57	0.78	0.32	0.56	0.57	0.44
Non Currrent Assets Other	-0.57	0.75	-0.37	-0.06	-0.78	-0.61	-0.26	0.7	0.38	-0.1	-0.61	0.05		-0.06	-0.61	-0.3	-0.07	0.71	-0.44	-0.3	-0.51	-0.51	0.64	0.18	-0.59	0.58
Other Assets	0.57	-0.18	0.31	0.36	0.41	0.4	0.48	-0.51	-0.28	0.19	0.58	0.46	-0.06		0.57	0.35	0.0	-0.08	0.3	0.11	0.71	0.36	0.05	0.17	0.56	0.04
Cash And Short Term Investments	0.97	-0.38	0.51	0.52	0.84	0.93	0.61	-0.98	-0.64	0.63	0.99	0.42	-0.61	0.57		0.56	0.28	-0.41	0.73	0.46	0.83	0.77	-0.2	-0.01	0.98	-0.1
Net Receivables	0.71	-0.57	0.93	0.78	0.51	0.66	0.98	-0.51	-0.93	0.48	0.51	0.82	-0.3	0.35	0.56		0.84	-0.32	0.92	0.96	0.59	0.81	0.0	0.31	0.69	0.12
Common Stock Shares Outstanding	0.41	-0.31	0.78	0.66	0.17	0.37	0.78	-0.2	-0.74	0.44	0.2	0.6	-0.07	0.0	0.28	0.84		-0.06	0.72	0.89	0.22	0.52	0.2	0.24	0.39	0.27
Non Current Liabilities Total	-0.41	0.81	-0.27	0.01	-0.82	-0.54	-0.29	0.55	0.31	-0.26	-0.4	0.0	0.71	-0.08	-0.41	-0.32	-0.06		-0.38	-0.29	-0.38	-0.45	0.93	0.26	-0.42	0.57
Capital Surpluse	0.84	-0.48	0.88	0.82	0.65	0.87	0.92	-0.69	-0.99	0.54	0.69	0.77	-0.44	0.3	0.73	0.92	0.72	-0.38		0.92	0.75	0.94	-0.06	0.28	0.83	0.21
Inventory	0.62	-0.51	0.92	0.77	0.43	0.62	0.92	-0.42	-0.94	0.46	0.4	0.77	-0.3	0.11	0.46	0.96	0.89	-0.29	0.92		0.47	0.79	0.02	0.28	0.6	0.18
Other Current Assets	0.86	-0.42	0.64	0.64	0.73	0.83	0.68	-0.81	-0.71	0.27	0.84	0.57	-0.51	0.71	0.83	0.59	0.22	-0.38	0.75	0.47		0.8	-0.14	0.31	0.86	0.12
Other Stockholder Equity	0.89	-0.5	0.79	0.82	0.75	0.9	0.84	-0.74	-0.94	0.56	0.73	0.78	-0.51	0.36	0.77	0.81	0.52	-0.45	0.94	0.79	0.8		-0.14	0.31	0.88	0.14
Total Liab	-0.14	0.69	0.06	0.36	-0.66	-0.29	0.02	0.38	-0.02	-0.08	-0.21	0.32	0.64	0.05	-0.2	0.0	0.2	0.93	-0.06	0.02	-0.14	-0.14		0.43	-0.16	0.71
Short Long Term Debt	0.13	-0.03	0.43	0.56	-0.13	0.07	0.32	0.08	-0.36	-0.17	-0.04	0.56	0.18	0.17	-0.01	0.31	0.24	0.26	0.28	0.28	0.31	0.31	0.43		0.11	0.43
Total Current Assets	1.0	-0.44	0.64	0.65	0.84	0.95	0.73	-0.95	-0.77	0.65	0.96	0.57	-0.59	0.56	0.98	0.69	0.39	-0.42	0.83	0.6	0.86	0.88	-0.16	0.11		-0.04
Short Term Debt	-0.02	0.63	0.13	0.54	-0.41	0.0	0.18	0.25	-0.27	0.03	-0.12	0.44	0.58	0.04	-0.1	0.12	0.27	0.57	0.21	0.18	0.12	0.14	0.71	0.43	-0.04

Click cells to compare fundamentals

Myomo Account Relationship Matchups

Myomo fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.6M	14.7M	20.1M	10.2M	14.6M	10.4M
Other Current Liab	1.7M	2.5M	2.8M	2.6M	3.3M	3.5M
Total Current Liabilities	3.9M	2.9M	4.3M	3.6M	5.5M	3.1M
Total Stockholder Equity	1.8M	11.6M	15.4M	6.4M	9.0M	4.9M
Net Tangible Assets	1.8M	11.6M	15.4M	6.4M	7.3M	7.7M
Property Plant And Equipment Net	155.0K	263.8K	908.2K	703.0K	839.3K	881.3K
Net Debt	(1.8M)	(12.1M)	(14.8M)	(4.8M)	(6.3M)	(6.6M)
Retained Earnings	(56.1M)	(67.7M)	(78.1M)	(88.8M)	(96.9M)	(92.1M)
Accounts Payable	450.1K	180.5K	723.4K	569.7K	1.1M	602.4K
Cash	4.5M	12.2M	15.5M	5.3M	6.9M	7.5M
Non Current Assets Total	449.2K	263.8K	908.2K	946.5K	930.6K	533.7K
Non Currrent Assets Other	219.2K	(263.8K)	95.3K	111.0K	91.2K	97.0K
Other Assets	294.2K	263.8K	19.8M	111.0K	127.7K	121.3K
Cash And Short Term Investments	4.5M	12.2M	15.5M	5.3M	8.9M	7.7M
Net Receivables	424.3K	924.9K	2.0M	1.9M	2.4M	2.5M
Common Stock Shares Outstanding	553.8K	3.3M	5.8M	7.1M	29.5M	31.0M
Liabilities And Stockholders Equity	6.6M	14.7M	20.1M	10.2M	14.6M	10.4M
Non Current Liabilities Total	890.5K	274.7K	402.9K	200.7K	115.2K	109.4K
Capital Surpluse	58.0M	79.3M	93.5M	95.1M	109.4M	114.8M
Inventory	439.5K	707.1K	808.3K	1.4M	1.8M	1.9M
Other Current Assets	820.2K	1.1M	1.7M	573.5K	598.9K	681.3K
Other Stockholder Equity	58.0M	79.3M	93.5M	95.1M	105.8M	58.8M
Total Liab	4.8M	3.1M	4.7M	3.8M	5.6M	4.0M
Total Current Assets	6.1M	14.4M	19.2M	9.2M	13.7M	9.9M
Short Term Debt	1.8M	36.6K	666.8K	457.6K	972.3K	876.3K
Common Stock	57.0	457.0	687.0	775.0	2.7K	2.9K
Property Plant Equipment	155.0K	95.0K	908.2K	703.0K	808.5K	848.9K
Deferred Long Term Liab	44.0K	144.6K	219.2K	1.5K	1.3K	1.3K
Current Deferred Revenue	3.0K	2.5K	192.8K	20.7K	8.5K	8.1K
Common Stock Total Equity	1.1K	1.2K	57.0	457.0	411.3	477.6
Property Plant And Equipment Gross	155.0K	263.8K	1.3M	703.0K	1.6M	1.7M
Cash And Equivalents	4.5M	12.2M	15.5M	5.3M	6.1M	9.1M
Net Invested Capital	4.5M	11.6M	15.4M	6.4M	9.0M	10.3M

Pair Trading with Myomo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.

Moving together with Myomo Stock

0.62	EW	Edwards Lifesciences Corp	Pair Corr
0.94	GH	Guardant Health	Pair Corr
0.76	LH	Laboratory	Pair Corr

Moving against Myomo Stock

0.77	DRIO	DarioHealth Corp	Pair Corr
0.69	EDAP	EDAP TMS SA	Pair Corr
0.63	VERO	Venus Concept	Pair Corr
0.38	CI	Cigna Corp Downward Rally	Pair Corr
0.31	VTAK	Catheter Precision Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.

The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:

How To Invest In Myomo

Details

Is Myomo Stock a good investment?

Details

What is Myomo's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.23)

Revenue Per Share

0.835

Quarterly Revenue Growth

0.813

Return On Assets

(0.31)

Return On Equity

(0.83)

The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Myomo Research Development vs Total Operating Expenses Analysis

Research Development vs Total Operating Expenses

Research Development vs Total Operating Expenses Correlation Analysis

Correlation Coefficient

Research Development

Total Operating Expenses

Myomo fundamental ratios Correlations

Myomo Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Myomo fundamental ratios Accounts

Pair Trading with Myomo

Moving together with Myomo Stock

Moving against Myomo Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Net Receivables	+ 0.98	Property Plant And Equipment Net
Total Current Assets	+ 0.98	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.96	Cash

Capital Surpluse	- 0.99	Retained Earnings
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Total Current Assets	- 0.95	Net Debt
Other Stockholder Equity	- 0.94	Retained Earnings
Inventory	- 0.94	Retained Earnings